199 related articles for article (PubMed ID: 2433247)
21. [Tumor markers in gastrointestinal cancer].
Shimano T; Monden T; Oji Y; Morimoto H; Tomita N; Mori T
Rinsho Byori; 1985 Aug; 33(8):853-60. PubMed ID: 3908746
[No Abstract] [Full Text] [Related]
22. Immunologic diagnosis of human digestive tract cancer. Carcinoembryonic antigens.
Kamholz SL
Am J Gastroenterol; 1973 Mar; 59(3):233-43. PubMed ID: 4121819
[No Abstract] [Full Text] [Related]
23. Immunohistochemical comparison of Lea, monosialosyl Lea (CA 19-9), and disialosyl Lea antigens in human colorectal and pancreatic tissues.
Itzkowitz SH; Yuan M; Fukushi Y; Lee H; Shi ZR; Zurawski V; Hakomori S; Kim YS
Cancer Res; 1988 Jul; 48(13):3834-42. PubMed ID: 3288336
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of monoclonal antibody to 19-9 antigen as a potential screening technique for colorectal cancer in a high-risk population.
Verrill H; Goldberg M; Kovac G; Atkinson B; Herlyn M
Prog Clin Biol Res; 1984; 156():107-14. PubMed ID: 6382320
[No Abstract] [Full Text] [Related]
25. [Application of mouse monoclonal antibody to the diagnosis of cancer].
Takahashi T; Ueda R
Gan To Kagaku Ryoho; 1986 Jun; 13(6):2015-22. PubMed ID: 2424372
[TBL] [Abstract][Full Text] [Related]
26. The clinical validity of circulating tumor-associated antigens CEA and CA 19-9 in primary diagnosis and follow-up of patients with gastrointestinal malignancies.
Staab HJ; Brümmendorf T; Hornung A; Anderer FA; Kieninger G
Klin Wochenschr; 1985 Feb; 63(3):106-15. PubMed ID: 3856076
[TBL] [Abstract][Full Text] [Related]
27. [Diagnosis of pancreatic carcinoma using 2 associated monoclonal antibodies].
Yao CZ; Zeng XJ; Wang SZ
Zhonghua Wai Ke Za Zhi; 1987 Nov; 25(11):655-8, 670. PubMed ID: 3482539
[No Abstract] [Full Text] [Related]
28. Useful blood tests in the diagnosis and management of cancer: a review. Part III Antigens and Antibodies.
Hartman HA; Foley JF
Nebr Med J; 1977 Jun; 62(6):184-9. PubMed ID: 69997
[No Abstract] [Full Text] [Related]
29. Carcinoembryonic antigen (CEA). Use and limitations of the CEA radioimmunoassay in the diagnosis and follow-up of colo-rectal carcinoma.
Mach JP; Pusztaszeri G; MacDonald D; Bertholet MM
Johns Hopkins Med J Suppl; 1974; 3():369-79. PubMed ID: 4421371
[No Abstract] [Full Text] [Related]
30. [Diagnosis of tumors with the use of immunologic tumor markers].
Vorlaender KO
Wien Med Wochenschr; 1983 Feb; 133(3):59-66. PubMed ID: 6189301
[No Abstract] [Full Text] [Related]
31. A multicentre evaluation of tumour marker determinations using the automatic Enzymun-Test Systems ES 300 and ES 600/700.
van Dalen A; Kessler AC
Eur J Clin Chem Clin Biochem; 1996 Apr; 34(4):377-84. PubMed ID: 8704058
[TBL] [Abstract][Full Text] [Related]
32. [Ca 12-5 in stomach and colorectal cancer. A comparison with the tumor markers CEA and Ca 19-9].
Quentmeier A; Schlag P; Geisen HP; Schmidt-Gayk H
Med Klin (Munich); 1986 Mar; 81(6):199-201. PubMed ID: 3466003
[No Abstract] [Full Text] [Related]
33. Immunohistochemical antigenic expression and in vivo tumor uptake of monoclonal antibodies with specificity for tumors of the gastrointestinal tract.
Douillard JY; Lehur PA; Aillet G; Kremer M; Bianco-Arco A; Peltier P; Chatal JF
Cancer Res; 1986 Aug; 46(8):4221-4. PubMed ID: 3524803
[TBL] [Abstract][Full Text] [Related]
34. [An overview of tumor markers].
Morita R; Fukunaga M; Ohtsuka N
Rinsho Hoshasen; 1986 Jan; 31(1):1-10. PubMed ID: 2422414
[No Abstract] [Full Text] [Related]
35. [Clinical evaluation of the tumor marker CA 19-9 in comparison with carcinoembryonic antigen (CEA) in surgical pre- and postoperative diagnosis].
Lorenz M; Happ J; Hottenrott C; Maul FD; Baum RP; Hör G; Encke A
Nuklearmedizin; 1986 Feb; 25(1):9-14. PubMed ID: 3459133
[TBL] [Abstract][Full Text] [Related]
36. [Differential cytology of effusions using monoclonal antibodies].
Lüttges J; Neumann K; Pflüger KH; Schmitz-Moormann P
Pathologe; 1988 May; 9(3):137-42. PubMed ID: 2457213
[No Abstract] [Full Text] [Related]
37. Expression of monoclonal antibody-defined tumor markers in four carcinomas.
Wu JT
Ann Clin Lab Sci; 1989; 19(1):17-26. PubMed ID: 2916833
[TBL] [Abstract][Full Text] [Related]
38. [Experiences with determining carcinoembryonic antigen in tumors of the digestive tract].
Pelikán A
Zentralbl Chir; 1986; 111(18):1113-8. PubMed ID: 3024422
[TBL] [Abstract][Full Text] [Related]
39. [Clinical evaluation of tumor markers in patients with colorectal cancer].
Naritaka Y; Ogawa K; Matsumoto N; Hosokawa T; Kikuchi T; Koyama N; Haga S; Kajiwara T; Sakakibara N
Gan No Rinsho; 1987 Aug; 33(10):1274-80. PubMed ID: 2444727
[TBL] [Abstract][Full Text] [Related]
40. [Clinical significance of carcinoembryonic antigen (CEA) plasma concentration in the 1st diagnosis of digestive-tract malignomas].
Auer IO; Münch L; Epping J; Schmid L
Z Gastroenterol; 1977 Aug; 15(8):491-503. PubMed ID: 906599
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
